Funds advised by Apax Partners LLP acquire remaining stake in European medical diagnostics leader Unilabs from Nordic Capital and Apax Partners France
The joint owners of Switzerland-based Unilabs, private equity funds Apax Europe VI, Nordic Capital Fund VI (“Nordic Capital”) and Apax France VII, announced today that Nordic Capital and Apax Partners France, have accepted an offer from Apax IX, advised by Apax Partners LLP, for the acquisition of their respective stakes in Unilabs.
Q2 2016 results - Unilabs delivers 8th consecutive quarter of organic sales and EBITDA growth
Q2 results delivered increased organic growth in net sales of 4.2% CER (1.8% reported) and organic EBITDA growth up by 20.1% CER (17.3% reported) on a like for like basis. The combination of constant revenue growth and excellent results from the Cost Leadership Initiative contributed to the substantial growth of EBITDA margins. The 2016 guidance is confirmed.

Our Partnerships, Expertise & Network

We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe.
Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services.
With operations in 12 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe.